ClinicalTrials.gg
RecruitingNCT05179083Updated Dec 6, 2023

Exercise for Brain Regeneration in Epilepsy

A Phase 1 interventional study of High-Impact Aerobic Exercise and Low-Impact Aerobic Exercise in Temporal Lobe Epilepsy, sponsored by University of Southern California. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-12-06.

Sponsored by University of Southern California · Phase 1, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Aug 2022; still recruiting 4 years 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 30 studies in Epilepsy, Temporal Lobe with a site in United States — 10 open to participants now, 10 under way, none of them phase 3. Epilepsy, Temporal Lobe · United States.

Planned enrollment
10th of 19
10 · median 10
Started
2022
the only one that year
Phase 1
2 of 30
2 open now
Registered
25th of 30
by date

Among the 30 studies in Epilepsy, Temporal Lobe with a site in United States, this one is the 10th largest by planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2022, is one of 2 in phase 1, and was the 25th registered.

Epilepsy, Temporal Lobe

65 studies on the registry are indexed under Epilepsy, Temporal Lobe; 25 are open to participants now.

Browse Epilepsy, Temporal Lobe studies →

Open to participants now

10 of the 30 studies in Epilepsy, Temporal Lobe with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 19 Epilepsy, Temporal Lobe studies recruiting now, 6 (32%) set no upper age limit and 9 (47%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Epilepsy, Temporal Lobe with a site in United States, or all of them as a file.
02

Study summary

Nearly 100 million Americans are affected by neurological disorders with an overall cost above $765 billion for the more prevalent conditions. Given this significant burden, effective treatments to prevent dementia and new disease modifying therapies are urgently needed.

Regeneration of lost neurons with new ones (i.e., neurogenesis) is compromised at early stages of dementia and in part correlates with cognitive impairment in Alzheimer's disease. Boosting the neurogenesis delays the cognitive impairment in animal models of dementia and has been proven beneficial in improving the memory in rodent studies.

Aerobic exercise is the most potent known stimulator of neurogenesis in animal models. A crucial next step is to translate endogenous regenerative strategies to people. The purpose of this study is to demonstrate the feasibility and investigate the effects of an exercise program on neurogenesis and cognitive improvement in epilepsy patients.

Read the detailed description

Neurogenesis studies in healthy and dementia patients have only been performed on postmortem tissue, which prevents investigation of treatment outcomes. Patients with mesial temporal lobe epilepsy (MTLE) typically do not respond to medications and uniquely among related dementia disorders undergo corrective surgical treatment, providing a unique opportunity to study the value of regenerative interventions on hippocampal electrophysiology and neurogenesis. Using this unique approach, this study will investigate the neurogenesis and cognitive improvement in epilepsy patients.

Ten people with MTLE who are recommended for surgical treatment as part of their standard care will be enrolled and randomly assigned to High Impact (n=5) and Low Impact (n=5) exercise groups. The duration of exercise programs will be 12 weeks and study arms will undergo the same protocol except for the target heart rate which will be higher in the High-Impact group. Exercise will be performed at home using a recliner bike under the supervision of caregiver and study personnel. Participants will undergo cognitive, exercise and clinical assessment at baseline and after completing the three-month exercise therapy; then surgically resected tissue will be analyzed for regeneration and epileptiform activity. The investigators will assess whether exercise would yield clinical benefits in terms of seizure frequency/intensity or cognitive ability, and whether the ability of the adult human brain to self-repair can be enhanced. It is hypothesized that the proposed exercise regimen is feasible and will improve the neurogenesis levels and cognition.

03

Conditions studied

  • Temporal Lobe Epilepsy

Keywords

  • Exercise
  • Neurogenesis
  • Mesial temporal lobe epilepsy
  • Regeneration
  • Cognition
  • Electrophysiology
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age of 18 years or older
  • Medically resistant mesial temporal lobe epilepsy
  • Candidacy for standard or selective temporal lobectomy

Exclusion criteria

Exclusion Criteria:

  • Age of older than 65 years
  • Pregnancy
  • Physical disabilities or medical conditions preventing from participation in exercise program
  • Inability to receive exercise equipment at home
  • Cognitive/developmental disabilities restricting the participation in exercise program
05

Study design

Phase
Phase 1
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    High-impact Exercise

    Other: High-Impact Aerobic Exercise

  • Active comparator
    Low-impact Exercise

    Other: Low-Impact Aerobic Exercise

Interventions

  • OtherHigh-Impact Aerobic Exercise

    Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.

  • OtherLow-Impact Aerobic Exercise

    Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.

06

What researchers measure

Primary outcomes

  1. Adherence to exercise and assessments

    Number of completed exercise and assessment sessions

    Time frame: Through study completion, an average of 6 months

Secondary outcomes

  1. Neurogenesis

    Number of new neurons per mm3 in surgically resected tissue after cell culture

    Time frame: 13 weeks after first exercise session

  2. Rey Auditory Verbal Learning Test (RAVLT) - Trial V

    The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Trial V is the 5th attempt at recalling the first list of words.

    Time frame: Baseline and 12 weeks after first exercise session

  3. Rey Auditory Verbal Learning Test (RAVLT) - Summary score

    The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Summary score is the sum of number of words learned over five learning trials.

    Time frame: Baseline and 12 weeks after first exercise session

  4. WAIS-IV - Matrix Reasoning

    Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV) is a validated test of cognitive ability and intelligence. Matrix reasoning is among the tasks included in WAIS-IV which is used to assess non-verbal abstract problem solving and inductive reasoning.

    Time frame: Baseline and 12 weeks after first exercise session

  5. Rey Complex Figure Test (RCFT)

    Rey Complex Figure Test (RCFT) is a standardized test of visuospatial memory. Performance will be scored based on the delayed recall trial of the RCFT.

    Time frame: Baseline and 12 weeks after first exercise session

07

Study locations

1 of 1 sites recruiting
  • University of Southern California Department of Neurosurgery
    Los Angeles, California 90033, United States
    Recruiting
    • Jonathan J Russin, MD · Contact323-226-2271
08

References and documents

Publications

  • Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017 Apr;81(4):479-484. doi: 10.1002/ana.24897. No abstract available. PubMed 28198092 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2022 (actual). Primary completion is estimated for Aug 2024, 24 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 30, 2021
First posted
Jan 5, 2022
StartActual
Aug 20, 2022
Primary completionEst.
Aug 31, 2024
CompletionEst.
Aug 31, 2024
Last update
Dec 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05179083
Responsible party
Jonathan Russin (Assistant Professor of Clinical Neurological Surgery, University of Southern California) — Principal investigator
First posted
Jan 5, 2022
Start date
Aug 20, 2022
Primary completion
Aug 31, 2024 (estimated)
Completion
Aug 31, 2024 (estimated)
Last update
Dec 6, 2023

Study contacts

Jonathan J Russin, MD
Contact
Jonathan.Russin@med.usc.edu
800-872-2273
Jonathan J Russin, MD
principal investigator · University of Southern California

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion